dc.contributor.author | Ndhlovu, Zaza M. | |
dc.contributor.author | Kamya, Philomena | |
dc.contributor.author | Mewalal, Nikoshia | |
dc.contributor.author | Kløverpris, Henrik N. | |
dc.contributor.author | Nkosi, Thandeka | |
dc.contributor.author | Pretorius, Karyn | |
dc.contributor.author | Laher, Faatima | |
dc.contributor.author | Ogunshola, Funsho | |
dc.contributor.author | Chopera, Denis | |
dc.contributor.author | Ghebremichael, Musie | |
dc.contributor.author | Ismail, Nasreen | |
dc.contributor.author | Moodley, Amber | |
dc.contributor.author | Malik, Amna | |
dc.contributor.author | Leslie, Alasdair | |
dc.contributor.author | Goulder, Philip J.R. | |
dc.contributor.author | Buus, Søren | |
dc.contributor.author | Dong, Krista | |
dc.contributor.author | Ndung’u, Thumbi | |
dc.contributor.author | Walker, Bruce D. | |
dc.contributor.author | Chakraborty, Arup K | |
dc.contributor.author | Shekhar, Karthik | |
dc.date.accessioned | 2017-03-22T19:08:59Z | |
dc.date.available | 2017-03-22T19:08:59Z | |
dc.date.issued | 2015-09 | |
dc.date.submitted | 2015-06 | |
dc.identifier.issn | 1074-7613 | |
dc.identifier.issn | 1097-4180 | |
dc.identifier.uri | http://hdl.handle.net/1721.1/107652 | |
dc.description.abstract | CD8[superscript +] T cells contribute to the control of HIV, but it is not clear whether initial immune responses modulate the viral set point. We screened high-risk uninfected women twice a week for plasma HIV RNA and identified 12 hyperacute infections. Onset of viremia elicited a massive HIV-specific CD8[superscript +] T cell response, with limited bystander activation of non-HIV memory CD8[superscript +] T cells. HIV-specific CD8[superscript +] T cells secreted little interferon-γ, underwent rapid apoptosis, and failed to upregulate the interleukin-7 receptor, known to be important for T cell survival. The rapidity to peak CD8[superscript +] T cell activation and the absolute magnitude of activation induced by the exponential rise in viremia were inversely correlated with set point viremia. These data indicate that rapid, high magnitude HIV-induced CD8[superscript +] T cell responses are crucial for subsequent immune control of acute infection, which has important implications for HIV vaccine design. | en_US |
dc.description.sponsorship | Bill & Melinda Gates Foundation | en_US |
dc.description.sponsorship | Collaboration for AIDS Vaccine Discovery | en_US |
dc.description.sponsorship | Witten Family Foundation | en_US |
dc.description.sponsorship | Dan and Marjorie Sullivan | en_US |
dc.description.sponsorship | Ursula Brunner | en_US |
dc.description.sponsorship | Gary and Loren Cohen | en_US |
dc.description.sponsorship | Mark and Lisa Schwartz Foundation, | en_US |
dc.description.sponsorship | International AIDS Vaccine Initiative (UKZNRSA1001) | en_US |
dc.description.sponsorship | National Institute of Allergy and Infectious Diseases (U.S.) (R37AI067073) | en_US |
dc.description.sponsorship | Center for AIDS Research (P30 AI060354) | en_US |
dc.language.iso | en_US | |
dc.publisher | Elsevier/Cell Press | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1016/j.immuni.2015.08.012 | en_US |
dc.rights | Creative Commons Attribution-NonCommercial-NoDerivs License | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | en_US |
dc.source | PMC | en_US |
dc.title | Magnitude and Kinetics of CD8[superscript +] T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point | en_US |
dc.title.alternative | Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Ndhlovu, Zaza M. et al. “Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point.” Immunity 43.3 (2015): 591–604. | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Institute for Medical Engineering & Science | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Chemical Engineering | en_US |
dc.contributor.department | Ragon Institute of MGH, MIT and Harvard | en_US |
dc.contributor.mitauthor | Chakraborty, Arup K | |
dc.contributor.mitauthor | Shekhar, Karthik | |
dc.relation.journal | Immunity | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dspace.orderedauthors | Ndhlovu, Zaza M.; Kamya, Philomena; Mewalal, Nikoshia; Kløverpris, Henrik N.; Nkosi, Thandeka; Pretorius, Karyn; Laher, Faatima; Ogunshola, Funsho; Chopera, Denis; Shekhar, Karthik; Ghebremichael, Musie; Ismail, Nasreen; Moodley, Amber; Malik, Amna; Leslie, Alasdair; Goulder, Philip J.R.; Buus, Søren; Chakraborty, Arup; Dong, Krista; Ndung’u, Thumbi; Walker, Bruce D. | en_US |
dspace.embargo.terms | N | en_US |
dc.identifier.orcid | https://orcid.org/0000-0003-1268-9602 | |
mit.license | PUBLISHER_CC | en_US |